119th Congress · House bill · Last action Sep 1, 2026
H.R. 10212In Committee
To direct the Secretary of Veterans Affairs to study the potential benefits of peptide-based therapies for veterans receiving care through the Department of Veterans Affairs, and for other purposes.
Sponsor: Rep. Mace, Nancy (R-SC)Introduced Sep 1, 2026
✆
In plain English
H.R. 10212 directs the Department of Veterans Affairs to study whether peptide-based therapies could benefit veterans in VA care. The bill was introduced by Rep. Nancy Mace (R-SC) and referred to the House Committee on Veterans' Affairs.
Generated by ThePolitibase from the bill text and CRS summary. Read the official text →
Where it is in the process
✓
Introduced
Sep 1
✓
House committee
Sep 1
3
House floor
-
4
Senate
-
5
Signed
-
What happens next: Sits in committee. Needs a markup or favorable report to advance to the House floor.
Community vote
How readers of ThePolitibase feel about this bill. Reader sentiment only — not a scientific poll, and not a measure of public opinion.
- support · - oppose · - total
District map
Scroll or use + / − to zoom, drag to pan. Search a ZIP or district to jump there.
Hover a district to see the member and how they voted.
Add your voice
Reader sentiment only — not a scientific poll, one vote per network. Find your district above (by ZIP or code), then weigh in.
No district selected
Sponsor
NR
Cosponsors (0)
No cosponsors yet.
Activity timeline
Sep 1
1d ago
1d ago
Referred to the House Committee on Veterans' Affairs.
Sep 1
1d ago
1d ago
Introduced in House
Sep 1
1d ago
1d ago
Introduced in House
Read the bill text
Official text via Congress.gov. Opens in a new tab.
Full action log
All 3 recorded actions since introduction · Source: Congress.gov
Sep 1
HOUSEReferred to the House Committee on Veterans' Affairs.
Sep 1
Introduced in House
Sep 1
Introduced in House
Track this bill
Get an alert when it moves to the next stage or gets a vote.